Article

LASIK & PRK: still looks good ten years on

LASIK for myopia over -10 D is a safe procedure; myopic regression slows down with time and there is a high rate of best spectacle corrected visual acuity (BSCVA) increase in the long-term.

LASIK for myopia over -10 D is a safe procedure; myopic regression slows down with time and there is a high rate of best spectacle corrected visual acuity (BSCVA) increase in the long-term, according to Jorge Alio, MD and colleagues from the VISSUM Instituto Oftalmológico de Alicante and the Miguel Hernandez University Medical School, Spain.

A total of 196 myopic eyes (118 patients) with a mean preoperative spherical equivalent (SE) of -13.95±2.79 D were included in the study. Myopic LASIK was performed using the VISX 20/20 excimer laser (AMO) with a 6 mm ablation zone. Patients were evaluated at three months, one, two, five and 10 years.

At 10 years follow-up, 82 eyes (42%) were within ±1.00 D and 54 eyes (27.5%) had undergone re-treatments. The mean SE decreased, in eyes that did not receive re-treatments, with a mean rate of -0.25±0.18 D per year that slowed over time. Overall, 124 eyes (63%) demonstrated an increase in BSCVA after 10 years follow-up. Two eyes (1%), with more than 15 D myopic correction, developed corneal ectasia.

…and so does PRK

The same research team also claimed that photorefractive keratectomy (PRK) for myopia over -10 D is a safe procedure with a high rate of BSCVA increase in the long term.

In a further study, 70 eyes (50 patients) with myopia ranging between -10.00 and -17.75 D underwent myopic PRK with the VISX 20/20 excimer laser (AMO) with a 6 mm ablation zone and were followed-up for a ten-year period.

Twenty-eight eyes (40%) were within ±1.00 D at 10 years follow-up and 28 eyes (40%) underwent re-treatments. Mean SE decreased over 10 years at a rate of 0.23±0.30 D per year that slowed down with time. Forty-one eyes (58%) demonstrated an increase in BSCVA after 10 years and only five (7.1%) lost more than two lines of BSCVA. The mean corneal haze score decreased gradually from 0.87±0.83 at three months to 0.16±0.45 at 10 years.

The authors of these two studies suggest that both LASIK and PRK are safe and effective procedures for the correction of high myopia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.